PNC Financial Services Group Inc. Boosts Position in Encompass Health Co. (NYSE:EHC)

PNC Financial Services Group Inc. lifted its position in shares of Encompass Health Co. (NYSE:EHC) by 14.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 44,017 shares of the company’s stock after purchasing an additional 5,647 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Encompass Health were worth $4,254,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. UMB Bank n.a. grew its stake in Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after acquiring an additional 252 shares during the period. V Square Quantitative Management LLC lifted its holdings in Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after purchasing an additional 140 shares in the last quarter. Oakworth Capital Inc. purchased a new position in Encompass Health in the 2nd quarter valued at $40,000. Benjamin F. Edwards & Company Inc. lifted its holdings in Encompass Health by 58.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after purchasing an additional 198 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in Encompass Health in the 2nd quarter valued at $58,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Stock Performance

NYSE EHC opened at $101.12 on Monday. The company has a market cap of $10.19 billion, a P/E ratio of 24.43, a P/E/G ratio of 1.32 and a beta of 0.88. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The stock has a 50-day moving average of $97.11 and a two-hundred day moving average of $90.88. Encompass Health Co. has a 1-year low of $63.78 and a 1-year high of $104.55.

Encompass Health (NYSE:EHC) last released its earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.09. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. Encompass Health’s revenue was up 11.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.86 EPS. As a group, analysts anticipate that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s dividend payout ratio is presently 16.43%.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. Truist Financial restated a “buy” rating and issued a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Stephens reiterated an “overweight” rating and set a $105.00 price target on shares of Encompass Health in a report on Tuesday, August 6th. UBS Group lifted their price target on Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, September 25th. Barclays lifted their price target on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Finally, KeyCorp boosted their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Nine equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.